Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Yasheng Group
Yasheng Group Resumes Plan to Pay Preferred Dividend to Common Shareholders; Raise Capital for our Subsidiary, Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to M
Business
Jan 20 2023
4 min read

Yasheng Group Resumes Plan to Pay Preferred Dividend to Common Shareholders; Raise Capital for our Subsidiary, Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to M